MM

Matthew Mulvey

NU New York University: 7 patents #85 of 1,640Top 6%
BB Benevir Biopharm: 5 patents #1 of 4Top 25%
SE Sequella: 2 patents #7 of 10Top 70%
📍 Baltimore, MD: #382 of 4,923 inventorsTop 8%
🗺 Maryland: #3,153 of 35,612 inventorsTop 9%
Overall (All Time): #503,192 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11147846 Oncolytic herpes simplex virus and therapeutic uses thereof Ian J. Mohr 2021-10-19
10456432 Oncolytic herpes simplex virus and therapeutic uses thereof Ian J. Mohr 2019-10-29
10232003 Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof Steven R. Fuhrmann, Ram Aiyar 2019-03-19
10105404 Oncolytic herpes simplex virus and therapeutic uses thereof Ian J. Mohr 2018-10-23
9623059 Oncolytic herpes simplex virus and therapeutic uses thereof Ian J. Mohr 2017-04-18
8709397 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response Ian J. Mohr 2014-04-29
8501400 Methods and compositions for determining the pathogenic status of infectious agents Leo Einck, Katherine Sacksteder 2013-08-06
8252277 Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response Ian J. Mohr 2012-08-28
7919234 Methods and compositions for determining the pathogenic status of infectious agents Leo Einck, Katherine Sacksteder 2011-04-05
7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response Ian J. Mohr 2010-06-08